论文部分内容阅读
目的观察麝香保心丸佐治急性冠脉综合征(ASC)的临床疗效。方法将160例ACS患者随机分为治疗组和对照组各80例。对照组给予常规西医治疗,治疗组在其基础上加用麝香保心丸治疗,观察并对比2组患者治疗前后的C-反应蛋白(CRP)、肌酸激酶同工酶(CK-MB)、肌钙蛋白T(c Tn T)值及治疗有效率。结果治疗后2组血清CRP、CK-MB、c Tn T水平低于治疗前,心律失常发生率低于治疗前,且治疗组变化幅度大于对照组,治疗组总有效率为90.0%高于对照组的77.5%,差异均有统计学意义(P<0.05)。结论常规西医治疗加服麝香保心丸治疗ACS具有很好的临床效果。
Objective To observe the clinical efficacy of “Shexiang Baoxin Pill” in treating acute coronary syndrome (ASC). Methods 160 patients with ACS were randomly divided into treatment group and control group of 80 cases. The control group was given routine Western medical treatment. The treatment group was treated with “Shexiang Baoxin Pill”. The levels of C-reactive protein (CRP), creatine kinase (CK) MB, Troponin T (c Tn T) value and therapeutic efficiency. Results The serum levels of CRP, CK-MB and cTnT in the two groups after treatment were lower than those before treatment, and the incidence of arrhythmia was lower than that before treatment, and the changes in the treatment group were greater than those in the control group. The total effective rate was 90.0% Group, 77.5%, the difference was statistically significant (P <0.05). Conclusion Conventional Western medical treatment plus service of heart-protecting musk pill has a good clinical effect.